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Book Reviews
International Histological Classification
of Tumours: No. 14. Histological and
Cytological Typing of Neoplastic Dis-
eases of Haematopoietic and Lymphoid
Tissues. (1976). G. MATHEI and H.
RAPPAPORT. Geneva: World Health Orga-
nization. 45 pp. plus 124 colourillustrations.
Book only, Sw.Fr. 75, U.S. $30.00. Book
with set oftransparencies, Sw.Fr. 200, U.S.
$80.00.
The object of this series is to establish an
internationally agreed classification and
nomenclature of tumour types, acceptable to
pathologists, clinicians and epidemiologists.
The need for such an enterprise has long been
evident. Since this series was launched in
1967, 13 volumes have appeared, the best of
them setting a very high standard. Each
volume consists of a summary classification,
brief explanatory notes, and a series of colour
photomicrographs. These illustrations can
be supplied as a set of colour transparencies,
at extra cost.
The authors of this volume have had a
particularly difficult task. Concepts of hae-
mopoietic and lymphoid neoplasia are, as they
note, in an unstable state, owing to the speed
of developments in this area. New theories
of histogenesis, and new systems of nomen-
clature, are constantly being put forward, yet
diagnostic precision is ever more mandatory
with the advent of specific chemotherapeutic
regimes. Consideration of these develop-
ments has in fact delayed publication of this
volume, but the authors have now courage-
ously decided to commit themselves to an
admittedly provisional classification, in the
hope ofproviding at least an agreed method of
recording data while conceptual work con-
tinues. The names of Mathe and Rappaport
on the title-page are assurance enough of an
authoritative approach, but the authors
modestly present their classification as a
provisory one. Since there is little sign of a
definitive classification (based on agreed
ultrastructural, immunological and cyto-
chemical foundations) emerging, the present
classification may well hold the field for some
years to come.
A broad view of the subject is taken, and
" borderline " neoplastic states are included,
as well as rarities. There are bound to be
disagreements with some of the authors'
concepts. Some will be surprised at the
disappearance of histiocytic lymphomas,
others at the survival of reticulosarcoma, for
example. But for laboratory workers, re-
quired to make a diagnosis, with all its
therapeutic implications, on the basis of
routinely-stained marrow smears or histo-
logical sections, this book will be of inestim-
able value.
The volumes ofthis series stand or fall on
the quality of the colour illustrations. This
volume succeeds triumphantly: the photo-
micrographs, mostly of Giemsa-stained
marrow smears or of H-and-E-stained sec-
tions, are nearly all of superb quality, and
the transparencies will be widely used for
teaching.
A sign ofthe times is that the book comes
in a flexible, rather than a hardback, cover.
The price may seem high, but this is an
essential book for all those working in the
field of the lymphomas and leukaemias,
whether in teaching, research, diagnosis or
therapy.
0. G. DODGE
Chemotherapy, Cancer Chemotherapy I
(Vol. 7) and II (Vol. 8). Eds K. HELL-
MANN and T. A. CONNORS (1976). New
York: Plenum Press. Vol. 7, 364 pp.;
Vol. 8, 618 pp. Price $42.00 each.
These volumes are the last 2 volumes of
reports of papers given at the 9th Inter-
national Congress of Chemotherapy held in
London in July 1975. The International
Society ofChemotherapy meets every 2 years
to review progress in chemotherapy of
infection and malignant disease. Some selec-
tion of papers actually delivered has been
made, and about 14 o of the papers delivered
on all subjects are included.
Within these 2 volumes, no obvious
grouping has been made, and although there
is a contents page to each volume and a list
ofauthors, there is no subject or author index
available to assist the reader.
The first 2 review papers in Vol. 7 (Sym-BOOK REVIEWS 125
posia) by E. Frei III (Advances in Cancer
Chemotherapy) and N. Brock (Experimental
Basis ofCancerChemotherapy) make interest-
ing reading for the general reader. The
remaining 43 contributions concern many
specific aspects of both experimental and
clinical cancer chemotherapy, in a grouping
which is difficult to appreciate, due to the
lack of subtitles. Vol. 8 (free papers)
continues with a further 95 titles on a wide
variety of topics, arranged in order of their
appearance in the original programme. It is
unfort;unate that the session titles were not
used to subtitle the subject material in this
volume.
The difficulties experienced by the reader
in locating material of special interest are no
less than those which must have been experi-
enced by the editors in their decision to avoid
indexing and subject grouping. The very
broad spectrum of material might rule out a
subject index, on a cost basis alone. The
real value ofthis type of conference report is
thus questionable, especially since the im-
portant material will be published in the
usual scientific and medical periodicals, where
a critical appraisal would require to be
exercised. A single book, selecting only the
main review lectures from the entire con-
ference would have been more useful, and
cheaper to both contributors and readers.
B. W. Fox
IARC Monographs on the Evaluation of
Carcinogenic RiskofChemicalsto Man.
Vol. 10: Some Naturally Occurring
Substances. LARC Working Group.
(1976). Lyon: IRAC. 353 pp. Price
Sw.Fr. 38., U.S. $15.20.
The latest, volume in this series of mono-
graphs which covers the carcinogenic risks of
a wide range of compounds, is in the same
format as previous volumes. It is not simply
a compendium of everything that is known
about a particular compound, but a summarv
of what the working party consider to be the
most relevant and significant studies. Fur-
ther, a conclusion is given on whether each
compound is considered to be carcinogenic or
not. Wheretheavailabledataareinadequate
this is clearly stated. This adds considerablv
to the value of the book, since the working
group was composed ofacknowledged special-
ists in this field.
For each compound, basic information,
such a-s synonyms (often a bewildering array),
formula, chemical and physical properties,
technical products, production, use, occur-
rence and analysis is given (with references)
prior to the presentation of data on carcino-
genic activity. This volume should be of
particular interest to clinicians, since a
number of the compounds covered are in
common use as drugs, e.g. actinomycin D,
adriamvcin, chloramphenicol, daunomycin,
griseofulvin, mitomycin C and reserpine. It
seems surprising that, while several of these
drugs were considered to be carcinogenic in
experimental animals, the working party
was unable to find any relevant data on their
effects in man. The report also considers
naturallv occurring substances which may
contaminate human foodstuffs, e.g. the
aflatoxins, cyeasin and the pyrrolizidine
alkaloids. The report does not cover sub-
stances which are known to be carcinogenic
but for which the identification of the
carcinogenic agent is not complete (e.g.
bracken, fern, tobacco, betel nut); nor does it
consider compounds formed from natural
products as a result of combustion or other
treatments. This is intended as a reference
work rather than as a book to be read, but
many of these excellent summaries are very
readable.
D. G. H-AR1PSDE-
IARC Monographs on the Evaluation of
CarcinogenicRiskofChemicalstoMan:
Vol. 11: Cadmium, Nickel, Some Ep-
oxides, Miscellaneous Industrial
Chemicals and General Considerations
on Volatile Anaesthetics. (1976).
Lyon: IARC. 306 pp. Price Sw.Fr. 34.00.
The eleventh volume in this series follows
in the worthy tradition ofits predecessors and
contains a wealth ofuseful information on the
compounds selected for evaluation.
Cadmium and nickel were considered in
Vol. 2 and the data on the carcinogenic
activity of these 2 metals is brought up to
date. Most of the new information supports
earlier observations. Both metals are car-
cinogenic to experimental animals when
aministered by the subcutaneous route, and
nickel has been shown to be carcinogenic also
in inhalation studies. While epidemiological
evidence indicates that nickel is carcinogenic
to man, the evidence on cadmium is much less